An amazing breakthrough by $RVMD that should see the name rally not just on pancreatic cancer TAM but on the “copy paste” potential for them to use RAS being a druggable target for further things beyond pancreatic cancer. We detailed this dynamic in our 26 Trades for 2026. https://t.co/UVL3uVmc0G